MedPath
TGA Approval

L Reuteri Oral Powder (489282)

489282

L Reuteri Oral Powder

Spectrumceuticals Pty Ltd

May 20, 2025

Medicine

Medicine

Active

Listed

Active Ingredients

Lactobacillus reuteri

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

L Reuteri Oral Powder (489282) - TGA 批准文号 | MedPath